These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 32301493

  • 1. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.
    Rishi G, Secondes ES, Wallace DF, Subramaniam VN.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32301493
    [Abstract] [Full Text] [Related]

  • 2. The molecular basis of ferroportin-linked hemochromatosis.
    De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J.
    Proc Natl Acad Sci U S A; 2005 Jun 21; 102(25):8955-60. PubMed ID: 15956209
    [Abstract] [Full Text] [Related]

  • 3. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S, Jormakka M, Mackenzie B, Ganz T, Nemeth E.
    Blood; 2018 Feb 22; 131(8):899-910. PubMed ID: 29237594
    [Abstract] [Full Text] [Related]

  • 4. The molecular basis of hepcidin-resistant hereditary hemochromatosis.
    Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E.
    Blood; 2009 Jul 09; 114(2):437-43. PubMed ID: 19383972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J, Pu C, Lang L, Qiao L, Abdullahi MA, Jiang C.
    Histol Histopathol; 2016 Aug 09; 31(8):833-40. PubMed ID: 27031690
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
    Ledesma-Colunga MG, Baschant U, Fiedler IAK, Busse B, Hofbauer LC, Muckenthaler MU, Altamura S, Rauner M.
    Bone; 2020 Aug 09; 137():115400. PubMed ID: 32380257
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of hepcidin and ferroportin in full term placenta of pregnant cows.
    Roperto S, Russo V, Urraro C, Cutarelli A, Perillo A, De Falco F, Roperto F.
    Theriogenology; 2017 Nov 09; 103():90-97. PubMed ID: 28780484
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
    Altamura S, Kessler R, Gröne HJ, Gretz N, Hentze MW, Galy B, Muckenthaler MU.
    Cell Metab; 2014 Aug 05; 20(2):359-67. PubMed ID: 25100063
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of ferroportin polymorphism on iron homeostasis and infection.
    Kasvosve I.
    Clin Chim Acta; 2013 Feb 01; 416():20-5. PubMed ID: 23178444
    [Abstract] [Full Text] [Related]

  • 18. Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin down-regulation.
    De Domenico I, Lo E, Ward DM, Kaplan J.
    Blood; 2010 Apr 08; 115(14):2956-9. PubMed ID: 20124516
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.